These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 16021533)
1. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Pawlik TM; Ross MI; Johnson MM; Schacherer CW; McClain DM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE Ann Surg Oncol; 2005 Aug; 12(8):587-96. PubMed ID: 16021533 [TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
3. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497 [TBL] [Abstract][Full Text] [Related]
6. [Risk factors for in-transit metastasis in patients with cutaneous melanoma]. Clemente-Ruiz de Almiron A; Serrano-Ortega S Actas Dermosifiliogr; 2012 Apr; 103(3):207-13. PubMed ID: 21899829 [TBL] [Abstract][Full Text] [Related]
7. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
8. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection. Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and survival differences between upper and lower extremity melanomas. Egger ME; Tabler BL; Dunki-Jacobs EM; Callender GG; Scoggins CR; Martin RC; Quillo AR; Stromberg AJ; McMasters KM Am Surg; 2012 Jul; 78(7):779-87. PubMed ID: 22748538 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma. Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166 [TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778 [TBL] [Abstract][Full Text] [Related]
13. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Chao C; Wong SL; Ross MI; Reintgen DS; Noyes RD; Cerrito PB; Edwards MJ; McMasters KM; Am J Surg; 2002 Dec; 184(6):520-4; discussion 525. PubMed ID: 12488154 [TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183 [TBL] [Abstract][Full Text] [Related]
15. Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients. Faut M; Wevers KP; van Ginkel RJ; Diercks GF; Hoekstra HJ; Kruijff S; Been LB; van Leeuwen BL Ann Surg Oncol; 2017 Jan; 24(1):142-149. PubMed ID: 27646020 [TBL] [Abstract][Full Text] [Related]
16. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma. Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591 [TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Gutzmer R; Al Ghazal M; Geerlings H; Kapp A Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience. Fairbairn NG; Orfaniotis G; Butterworth M J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263 [TBL] [Abstract][Full Text] [Related]